Schiff Institute Science and Innovation Advisory Board
Schiff Vitamins has an over 100-year history in creating science-backed dietary supplements. An integral part of our creation process is to listen and learn from scientific experts.
This is why we have created the Schiff Institute Science and Innovation Advisory Board. Each board member is a leader in their scientific area of expertise. Our board includes experts in the microbiome, brain health, nutrigenomics and personalized nutrition, omega-3s, public health nutrition, and dietary supplements. This diverse team of thought leaders provides us with key insights to guide our product innovations and to inform our team on scientific developments in nutrition and health.
Meet the Schiff Institute Science and Innovation Advisory Board
Regan Bailey, PhD, RD, MPHProfessor of Nutrition Science, Purdue University
Regan Bailey, PhD, RD, MPHProfessor of Nutrition Science, Purdue University
Dr. Regan Bailey is a Professor in the Department of Nutrition Science at Purdue University, and directs the Indiana Clinical and Translational Science Institute, Purdue Diet Assessment Center. Prior to Purdue, Dr. Bailey was a Nutritional Epidemiologist and Director of Career Development and Outreach at the NIH Office of Dietary Supplements. Dr. Bailey is a Registered Dietitian who completed a dietetic internship and M.S. in Food and Nutrition from the Indiana University of Pennsylvania. Dr. Bailey received her Ph.D. in Nutrition Science from The Pennsylvania State University. Dr. Bailey completed an M.P.H from the Bloomberg School of Public Health at Johns Hopkins University. The focus of research in the Bailey lab is to improve the methods of measuring nutritional status to optimize health. She utilizes nationally-representative survey data to characterize the American dietary landscape, to identify the optimal methods for assessment of biomarkers of nutritional status, and importantly, to understand how dietary intakes relate to health outcomes. She is the author of more than 130 peer-reviewed scientific publications, and has recently been elected to the National Academy of Medicine for her research contributions.
David Chernoff, MDChief Medical Officer, SetPoint Medical
Dr. David Chernoff is Chief Medical Officer at SetPoint Medical. Dr. Chernoff previously served as the Chief Medical Officer for Schiff Nutrition and OLLY. As a molecular diagnostics and biopharmaceutical industry veteran, he has played pivotal roles in moving early stage R&D programs successfully through clinical development and product commercialization and evaluating a broad range of in-licensing opportunities. Dr. Chernoff has served as a translational medicine consultant to more than 40 biotechnology, pharmaceutical and medical device companies and has held Chief Medical Officer posts with a number of companies, including Crescendo Bioscience, Adamas Pharma, XDX, CardioDX, Tethys Biosciences and Aquinox Pharma. He has also served as Vice President of Corporate Technology at Elan Pharmaceuticals and Medical Director at Chiron Diagnostics, where he played a pivotal role in the development of viral load assays for HIV, HCV, HBV and CMV. Additionally, he has held positions as principal with life sciences management consulting firm, Keelin Reeds Ventures, and entrepreneurin-residence and operating partner at TPG Biotech VC Fund.
Suzanne Devkota, PhDDirector, Microbiome Research, Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai Medical Center
Dr. Suzanne Devkota is the Director of Microbiome Research at Cedars-Sinai Medical Center in Los Angeles, and Assistant Professor of Medicine at UCLA investigating the role of the gut microbiome in inflammatory bowel diseases. Her research into dietary impacts on host-microbe interactions has led to some of the first mechanistic insights into why diseases such as inflammatory bowel diseases have rapidly increased over the last 50-100 years. Her ongoing research focuses on the role of pathobionts- symbiotic microbes that turn pathogenic under certain selective pressures- on host immune responses, and counteractive nutritional therapies. Dr. Devkota received her B.S in Biology and Chemistry from the University of Illinois at Urbana-Champaign, where she also received her M.S. in Nutritional Sciences. She earned her Ph.D from The University of Chicago in Molecular Metabolism and Nutrition where she began specializing in Gastroenterology and the newly emerging field of the Microbiome. She completed her post-doctoral training at the Joslin Diabetes Center at Harvard Medical School and is an alumnus of the Branco Weiss Fellowship.
William Harris, PhD, FAHA, FASNProfessor in the Department of Medicine at the Sanford School of Medicine, University of South Dakota; Founder of OmegaQuant Analytics, LLC; President of Fatty Acid Research Institute (FARI)
Dr. William Harris is a Professor in the Department of Internal Medicine at the Sanford School of Medicine at the University of South Dakota, the Founder of OmegaQuant Analytics, LLC, and the President of the newly-created Fatty Acid Research Institute. He obtained his PhD in Human Nutrition from the University of Minnesota and completed post-doctoral fellowships in Clinical Nutrition and Lipid Metabolism. Dr. Harris co-invented and defined the Omega-3 Index, a standardized method for Omega-3 fatty acid analysis which has been used in hundreds of research studies and tested in millions of patients. He has received five NIH grants for studies on the effects of Omega-3 fatty acids (EPA and DHA) on human health and has authored over 300 publications related to Omega-3 fatty acids in medical literature. Dr. Harris was also an author of three American Heart Association (AHA) scientific statements on fatty acids, all of which were published in the AHA journal, Circulation.
José Ordovás, PhDSenior Scientist and Director of the Nutrition and Genomics Laboratory USDA-Human Nutrition Research Center on Aging at Tufts University and Professor of Nutrition, Genetics and Pharmacology.
Dr. José Ordovás is Senior Scientist and Director of the Nutrition and Genomics Laboratory at the JM-USDA-Human Nutrition Research Center on Aging at Tufts University. In addition, he is Professor of Nutrition at the Friedman School of Nutrition Science and Policy, and Genetics and Pharmacology at the Tufts Graduate School of Biomedical Sciences. Dr. Ordovás’ research focuses on the genetic factors that predispose individuals to heart disease and obesity, as well as the interaction of these genetic factors with the environment and behavioral factors. He has published over 850 scientific articles in peer-reviewed journals, has authored numerous books and book chapters, and has spoken at hundreds of international congresses, symposia, and courses related to precision nutrition. He is considered a pioneer and one of the most distinguished world experts in gene-diet interactions related to chronic, age-related diseases.
Gary Small, MDPhysician in Chief, Behavioral Health, Hackensack Meridian Health, Chair of Psychiatry, Hackensack University Medical Center; Professor Emeritus of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles
Dr. Gary Small is Physician in Chief of Behavioral Health at Hackensack Meridian Health and Chair of Psychiatry at Hackensack University Medical Center. He is also Professor Emeritus of Psychiatry & Biobehavioral Sciences at UCLA. He has authored more than 500 scientific publications and 10 books, including The New York Times best seller, The Memory Bible. Dr. Small lectures throughout the world, and he and his research are frequently featured in national media including The New York Times, Wall Street Journal, London Times, Washington Post, TIME Magazine, Newsweek and numerous television programs. Dr. Small is also the recipient of many awards and honors, including the Jack Weinberg Award from the American Psychiatric Association and being named one of the world’s top 50 innovators in science and technology by Scientific American magazine.